Bank of America Issues Pessimistic Forecast for Immunovant (NASDAQ:IMVT) Stock Price
Immunovant (NASDAQ:IMVT – Free Report) had its price objective decreased by Bank of America from $38.00 to $33.00 in a research note published on Thursday,Benzinga reports. Bank of America currently has a buy rating on the stock. Other equities analysts have also issued reports about the stock. Jefferies Financial Group initiated coverage on shares of […]
Immunovant (NASDAQ:IMVT – Free Report) had its price objective decreased by Bank of America from $38.00 to $33.00 in a research note published on Thursday,Benzinga reports. Bank of America currently has a buy rating on the stock. Other equities analysts have also issued reports about the stock. Jefferies Financial Group initiated coverage on shares of […]
